Tue, March 29, 2022
Mon, March 28, 2022
Sun, March 27, 2022
Fri, March 25, 2022
Thu, March 24, 2022
Wed, March 23, 2022
Tue, March 22, 2022
Mon, March 21, 2022
Sun, March 20, 2022
Fri, March 18, 2022
Thu, March 17, 2022
Wed, March 16, 2022

Paul Choi Maintained (URGN) at Hold with Increased Target to $11 on, Mar 22nd, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-11-on-mar-22nd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Paul Choi of Goldman Sachs, Maintained "UroGen Pharma Ltd." (URGN) at Hold with Increased Target from $10 to $11 on, Mar 22nd, 2022.

Paul has made no other calls on URGN in the last 4 months.



There is 1 other peer that has a rating on URGN. Out of the 1 peers that are also analyzing URGN, 0 agree with Paul's Rating of Hold.



This is the rating of the analyst that currently disagrees with Paul


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $34 on, Tuesday, January 18th, 2022